Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Flu cases are spiking earlier than usual. What you need to know. - 2As her kidneys fail and time runs short, this activist fights to decriminalize euthanasia in Mexico
- 3Immortal Style: Closet Staples for Each Age
- 4At least 490 protesters killed in Iran, activists say
- 5'Euphoria' releases Season 3 trailer, premiere date: Watch Rue and Laurie finally face off
- A definitive Burger Confrontation: Which One Rules?
- Historic underwater structure discovered by divers off French coast
- Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
- How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- These Cities Led Global Jet-Setting In 2025, According To New Data
- Find the Captivating Professional flowerbeds of the US
- 6 Fledgling Cameras for 2024: Ideal for New Photographic artists
- Gaza amputees struggle to rebuild lives as the enclave faces shortages of prosthetic limbs
- Trump awarded 1st FIFA Peace Prize by Gianni Infantino at 2026 World Cup draw
